Discover how TACE treatment provides new hope for HIV-positive patients with hepatocellular carcinoma, with research showing similar survival outcomes to HIV-negative patients.
Exploring the efficacy of combining TACE with camrelizumab and targeted therapy for intermediate-stage unresectable hepatocellular carcinoma.